Syllable is an AI-enabled healthcare services company that transforms the way health systems provide access to care. Long call hold times, rerouted or dropped calls and dead ends can all contribute to a frustrating patient experience and make it cumbersome to access vital care quickly. Poor search functionality on the health system website and frustratingly hard to use patient portals confuse patients. Syllable helps patients navigate health care options with empathy, transparency and intelligence from the moment they request care by dialing the phone or visiting a health system's website. Since 2018, Syllable's solutions have been in use by some of the largest and most respected health systems across the United States.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/25/22 | $40,000,000 | Series C |
Oak HC/FT Section 32 TCV  Verily Life Sciences | undisclosed |
